retatrutide safety clinical trial retatrutide FDA Approval Status 2026: Everything We Know So Far Triple hormone receptor agonist retatrutide

You should keep this medicine in the fridge

However, it is important to inform your healthcare provider of all current medications and supplements to ensure there are no contraindications

As reported by the American Journal of Managed Care, the approval of an oral semaglutide formulation marked the beginning of what many are calling the oral GLP-1 era. In December 2025, the FDA approved the Wegovy (semaglutide) tablet as the first once-daily oral GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight

Like other well-known injectable weight-loss drugs, such as Wegovy (semaglutide) and Zepbound (tirzepatide), liraglutide helps regulate cravings and decrease appetite